您要查找的是不是:
- Objective To investigate the effect of T cell vaccination (TCV) on the survival time of cardiac allograft in rat. Methods Rat heterotopic cardiac transplantation was performed. 目的 探讨T淋巴细胞疫苗 (TCV)对大鼠移植心脏存活时间的影响及其机理。
- Objective To investigate the effect of T cell vaccination (TCV) on the survival time of cardiac allograft in rat.Methods Rat heterotopic cardiac transplantation was performed. 目的探讨T淋巴细胞疫苗(TCV)对大鼠移植心脏存活时间的影响及其机理。
- Effect of L-Arginine on Prolongation of Heterotopic Cardiac Allograft Survival Time in Rats 左旋精氨酸对大鼠异位心脏移植保护的作用
- heterotopic cardiac allograft 异位同种心脏移植术
- Conclusion This animal model is reliable of cardiac allograft vasculopathy. 结论该模型是一种可靠的移植物血管病的动物模型。
- The hallmark of cardiac allograft injury is the infiltration of leukocytes. 心脏同种异体移植物损伤的标志是粒细胞的浸润。
- Objective To modify the model of heterotopic cardiac transplantation in rat abdomen. 摘要目的建立大鼠腹腔异位心脏移植的动物模型。
- Objective To explore the role of donor specific blood transfusion (DST) and FK506 on heterotopic cardiac transplantation in rats. 目的探讨FK506和供体特异性输血在大鼠异位心脏移植中的作用。
- Objective To study the protective effect of scopolamine on cardiac allograft in rats and the mechanism. 目的研究东莨菪碱在心脏移植中延长供体心脏低温保存时间的作用,探讨其可能的机制。
- Cardiac allograft vasculopathy (CAV) continues to limit the long-term success of cardiac transplantation. 移植物冠状血管病持续限制心脏移植的远期成功。
- Objective:Cardiac allograft vasculopathy(CAV) has emerged as the most important limitation to the long-term survival of cardiac-transplant recipients. 目的:心脏移植物血管病(Cardiac allograft vasculopathy, CAV)是影响心脏移植患者术后长期存活的重要原因。
- Background Cardiac allograft vasculopathy(CAV) is a significant obstacle to improving outcomes in heart transplant recipients. 研究背景:移植心脏血管病(Cardiac allograft vasculopathy,CAV)是影响心脏移植病人长期存活的主要障碍。
- Objective: To evaluate the role of total glucosides of peony (TGP) as adjuvant therapy for prevention of cardiac allograft rejection in rats. 摘要目的:评价白芍总苷辅助预防大鼠心脏移植排斥反应约作用。
- Cytomegalovirus (CMV) has been shown to be a significant risk factor for the development of cardiac allograft vasculopathy. 而细胞巨化病毒被认为是引起该血管病变的主要危险因子。
- Background-: Cardiac allograft vasculopathy is the major limiting factor to the long-term success of pediatric heart transplantation. 背景:心脏同种异体移植物血管病变是导致小儿心脏移植术后远期效果欠佳的主要因素。
- Objective To explore the inhibitory effect of L-arginine on cardiac allograft vasculopathy (CAY) and its possible mechanisms. 目的 研究左旋精氨酸对心脏移植物血管病变的抑制作用及其机制。
- Conclusion Our results confirm the tolerance induced in a cardiac allograft by intrathymic and ALS pretreatment is permanent and it is specific for donor strain and tissue type. 结论同种异体心脏移植产生的特异性免疫耐受是胸腺内注射供体脾细胞和腹腔注射ALS共同作用的结果。
- Conclusion Cyclosporine and simulect have an effect in the prolongation of cardiac allograft survival in rats and the combination therapy shows an evident synergistic effect. 结论:环孢素A和舒莱可有效地抑制同种异体的移植排斥反应,联合应用有明显的协同作用。
- Method The expression levels of CD28, CTLA4, CD40 and CD40L molecules on PBMC were examined by immunohistochemical method in rat cardiac allograft recipients. 方法采用大鼠异位心脏移植模型,用免疫组化方法动态检测外周血单核细胞(PBMC)CD28、CTLA4、CD40及CD40L分子的表达。
- heterotopic cardiac transplantation 异位心脏移植